## **Core Concept**
Multiple Endocrine Neoplasia Type 2 (MEN-II) is a hereditary condition characterized by the occurrence of tumors in multiple endocrine glands. It is specifically associated with medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. The syndrome is caused by mutations in the RET proto-oncogene.

## **Why the Correct Answer is Right**
The correct answer, , is right because MEN-II syndrome is strongly associated with **medullary thyroid carcinoma (MTC)**. MTC originates from the parafollicular cells (also known as C cells) of the thyroid gland, which produce calcitonin. The RET proto-oncogene mutations lead to the constitutive activation of the RET receptor tyrosine kinase, promoting the development of MTC and other features of MEN-II.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because while papillary thyroid carcinoma is the most common type of thyroid cancer, it is not specifically associated with MEN-II syndrome.
- **Option B:** - This option is incorrect because follicular thyroid carcinoma, like papillary thyroid carcinoma, is not specifically linked to MEN-II syndrome.
- **Option D:** - This option is incorrect because anaplastic thyroid carcinoma is a highly aggressive and undifferentiated type of thyroid cancer, not directly associated with MEN-II syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **all patients with medullary thyroid carcinoma should be screened for RET gene mutations** to identify potential MEN-II syndrome. Early identification allows for prophylactic thyroidectomy and screening for other components of the syndrome.

## **Correct Answer: C. Medullary thyroid carcinoma**